Lidocaine/dextromethorphan - Endo/Indevus

Drug Profile

Lidocaine/dextromethorphan - Endo/Indevus

Alternative Names: LidodexNS

Latest Information Update: 19 Sep 2003

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Endo Pharmaceuticals; Indevus Pharmaceuticals
  • Class Antimigraines; Morphinans; Opioid analgesics; Small molecules
  • Mechanism of Action NMDA receptor antagonists; Opioid receptor agonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Migraine

Most Recent Events

  • 19 Sep 2003 Discontinued - Preclinical for Migraine in USA (Intranasal)
  • 15 May 2002 Interneuron Pharmaceuticals is now called Indevus Pharmaceuticals
  • 31 Dec 2001 Endo has been merged with and into Endo Pharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top